These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34169618)

  • 1. From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein-Templated Synthesis.
    Nozal V; García-Rubia A; Cuevas EP; Pérez C; Tosat-Bitrián C; Bartolomé F; Carro E; Ramírez D; Palomo V; Martínez A
    Angew Chem Int Ed Engl; 2021 Aug; 60(35):19344-19354. PubMed ID: 34169618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease.
    Iraji A; Firuzi O; Khoshneviszadeh M; Tavakkoli M; Mahdavi M; Nadri H; Edraki N; Miri R
    Eur J Med Chem; 2017 Dec; 141():690-702. PubMed ID: 29107423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Studies on Design and Development of Drugs Against Alzheimer's Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents.
    Gupta SP; Patil VM
    Curr Top Med Chem; 2020; 20(13):1195-1213. PubMed ID: 32297584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Structural Modification of BACE1 Inhibitors.
    Gu T; Wu WY; Dong ZX; Yu SP; Sun Y; Zhong Y; Lu YT; Li NG
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28025519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
    Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
    Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New flavonoid -
    Estrada-Valencia M; Herrera-Arozamena C; Pérez C; Viña D; Morales-García JA; Pérez-Castillo A; Ramos E; Romero A; Laurini E; Pricl S; Rodríguez-Franco MI
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):712-727. PubMed ID: 31852270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuritogenic activity of bi-functional bis-tryptoline triazole.
    Jiaranaikulwanitch J; Tadtong S; Govitrapong P; Fokin VV; Vajragupta O
    Bioorg Med Chem; 2017 Feb; 25(3):1195-1201. PubMed ID: 28043778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition.
    Estrada M; Pérez C; Soriano E; Laurini E; Romano M; Pricl S; Morales-García JA; Pérez-Castillo A; Rodríguez-Franco MI
    Future Med Chem; 2016 Jul; 8(11):1191-207. PubMed ID: 27402296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer's Disease.
    Rosales Hernández MC; Olvera-Valdez M; Velazquez Toledano J; Mendieta Wejebe JE; Fragoso Morales LG; Cruz A
    Molecules; 2024 Oct; 29(19):. PubMed ID: 39407708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer's Disease.
    Read J; Suphioglu C
    Cell Physiol Biochem; 2019; 53(2):413-428. PubMed ID: 31415717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology.
    Peters F; Salihoglu H; Rodrigues E; Herzog E; Blume T; Filser S; Dorostkar M; Shimshek DR; Brose N; Neumann U; Herms J
    Acta Neuropathol; 2018 May; 135(5):695-710. PubMed ID: 29327084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
    Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
    Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of arylquinones as BACE1 inhibitors, β-amyloid peptide aggregation inhibitors, and destabilizers of preformed β-amyloid fibrils.
    Ortega A; Rincón Á; Jiménez-Aliaga KL; Bermejo-Bescós P; Martín-Aragón S; Molina MT; Csákÿ AG
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2183-7. PubMed ID: 21441028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease.
    Ribaudo G; Coghi P; Zanforlin E; Law BYK; Wu YYJ; Han Y; Qiu AC; Qu YQ; Zagotto G; Wong VKW
    Bioorg Chem; 2019 Jun; 87():474-483. PubMed ID: 30927588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short peptide from sAPPα binding to BACE1-APP action site rescues Alzheimer-like pathology.
    Lai X; Hu J; Liu H; Lan L; Long Y; Gao X; Deng J
    Neurosci Lett; 2022 Jan; 770():136397. PubMed ID: 34915100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of BACE1 for therapeutic use in Alzheimer's disease.
    Luo X; Yan R
    Int J Clin Exp Pathol; 2010 Jul; 3(6):618-28. PubMed ID: 20661410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
    Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
    Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACE1 in Alzheimer's disease.
    Sathya M; Premkumar P; Karthick C; Moorthi P; Jayachandran KS; Anusuyadevi M
    Clin Chim Acta; 2012 Dec; 414():171-8. PubMed ID: 22926063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study.
    Ahmad SS; Akhtar S; Danish Rizvi SM; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):311-318. PubMed ID: 28413992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.